Quality of Life in Patients with Irritable Bowel Syndrome (IBS), Assessed Using the IBS–Quality of Life (IBS-QOL) Measure After 4 and 8 Weeks of Treatment with Mebeverine Hydrochloride or Pinaverium Bromide: Results of an International Prospective Observational Cohort Study in Poland, Egypt, Mexico and China

Publication | Open Access

DOI Full Paper Access

Citations

References

2014

Year

Xiaohua Hou, Shengliang Chen, Yali Zhang, Weihong Sha, Xiaofeng Yu, Hesham Elsawah, Afifi Fahmy Afifi, Hisham R El‐Khayat, Alaa Nouh, Mohamed Fathalla Hassan,

Clinical Drug Investigation